INKON Life Technology Co., Ltd. announced a private placement of 111,234,705 shares at an issue price of CNY 8.99 per share for the gross proceeds of not more than CNY 999,999,997.95 on August 12, 2022. The transaction will include participation from returning investor Qingdao Yingkang Medical Investment Co., Ltd. The transaction had a holding period of 36 months from the date of announcement. The transaction has been reviewed approved at the 24th (temporary) meeting of the fifth board of directors of the company, and still need to be reviewed and approved by the company's general meeting of shareholders, by the Shenzhen Stock Exchange and by the China Securities Regulatory Commission.